Literature DB >> 24819742

Evidence against a systemic arterial defect in patients with inflammatory bowel disease.

Luke A Neill1, Christine M Saundry2, Neil H Hyman3, George C Wellman4.   

Abstract

BACKGROUND: Despite increasing interest in local microvascular alterations associated with inflammatory bowel disease (IBD), the potential contribution of a primary systemic vascular defect in the etiology of IBD is unknown. We compared reactivity of large diameter mesenteric arteries from segments affected by Crohn disease (CD) or ulcerative colitis (UC) to an uninvolved vascular bed in both IBD and control patients.
METHODS: Mesenteric and omental arteries were obtained from UC, CD, and non-IBD patients. Isometric arterial contractions were recorded in response to extracellular potassium (K(+)) and cumulative additions of norepinephrine (NE). In addition, relaxation in response to pinacidil, an activator of adenosine triphosphate-sensitive K(+) channels was examined.
RESULTS: Contraction to K(+) and sensitivity to NE were not significantly different in arteries from CD, UC, and controls. Relaxation to pinacidil was also similar between groups.
CONCLUSIONS: Potassium-induced contractions and sensitivity to NE and pinacidil were not significantly different in large diameter mesenteric and omental arteries obtained from IBD patients. Furthermore, there was no significant difference in the sensitivity to K(+), NE, and pinacidil between mesenteric and omental arteries of CD and UC patients and those from non-IBD patients. Our results suggest an underlying vascular defect systemic to CD or UC patients is unlikely to contribute to the etiology of IBD.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Crohn disease; Inflammatory bowel disease; Mesenteric artery; Norepinephrine; Pinacidil; Potassium; Ulcerative colitis

Mesh:

Substances:

Year:  2014        PMID: 24819742      PMCID: PMC4160373          DOI: 10.1016/j.jss.2014.04.021

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  23 in total

1.  Clinical epidemiology of inflammatory bowel disease: Incidence, prevalence, and environmental influences.

Authors:  Edward V Loftus
Journal:  Gastroenterology       Date:  2004-05       Impact factor: 22.682

Review 2.  Ulcerative colitis.

Authors:  Silvio Danese; Claudio Fiocchi
Journal:  N Engl J Med       Date:  2011-11-03       Impact factor: 91.245

Review 3.  Perianal Crohn's disease: overview.

Authors:  S Ardizzone; G Bianchi Porro
Journal:  Dig Liver Dis       Date:  2007-08-27       Impact factor: 4.088

4.  Enhanced resistance artery sensitivity to agonists under isobaric compared with isometric conditions.

Authors:  W R Dunn; G C Wellman; J A Bevan
Journal:  Am J Physiol       Date:  1994-01

5.  ATP-sensitive K+ channel activation by calcitonin gene-related peptide and protein kinase A in pig coronary arterial smooth muscle.

Authors:  G C Wellman; J M Quayle; N B Standen
Journal:  J Physiol       Date:  1998-02-15       Impact factor: 5.182

Review 6.  Associations between NOD2/CARD15 genotype and phenotype in Crohn's disease--Are we there yet?

Authors:  Graham Radford-Smith; Nirmala Pandeya
Journal:  World J Gastroenterol       Date:  2006-11-28       Impact factor: 5.742

Review 7.  Biologic therapy for inflammatory bowel disease.

Authors:  Sandro Ardizzone; Gabriele Bianchi Porro
Journal:  Drugs       Date:  2005       Impact factor: 9.546

8.  Inhibition of Ca++ sparks by oxyhemoglobin in rabbit cerebral arteries.

Authors:  Ryan P Jewell; Christine M Saundry; Adrian D Bonev; Bruce I Tranmer; George C Wellman
Journal:  J Neurosurg       Date:  2004-02       Impact factor: 5.115

Review 9.  Mucosal healing in ulcerative colitis: pathophysiology and pharmacology.

Authors:  Jakob Benedict Seidelin; Mehmet Coskun; Ole Haagen Nielsen
Journal:  Adv Clin Chem       Date:  2013       Impact factor: 5.394

10.  Neoterminal ileal blood flow after ileocolonic resection for Crohn's disease.

Authors:  W J Angerson; M C Allison; J N Baxter; R I Russell
Journal:  Gut       Date:  1993-11       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.